Doripenem Treatment during Continuous Renal Replacement Therapy

Doripenem is a broad-spectrum parenteral carbapenem with enhanced activity against Pseudomonas aeruginosa. While the initial dosing recommendation for renally competent patients and patients undergoing continuous renal replacement therapy (cRRT) was 500 mg every 8 h (q8h), the dose for renally compe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Autores principales: Vossen, M. G., Wenisch, J. M., Maier-Salamon, A., Fritsch, A., Saria, K., Zuba, C., Jilch, S., Lemmerer, R., Unger, M., Jaehde, U., Jäger, W., Thalhammer, F.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2016
Materias:
Clinical Therapeutics
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4775919/
https://ncbi.nlm.nih.gov/pubmed/26711775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01801-15
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares